E. A. Copelan, Hematopoietic stem-cell transplantation, N Engl J Med, vol.354, pp.1813-1839, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00849640

A. Gratwohl, H. Baldomero, M. Aljurf, M. C. Pasquini, L. F. Bouzas et al., Hematopoietic stem cell transplantation: a global perspective, JAMA, vol.303, pp.1617-1641, 2010.

N. Khera, S. B. Zeliadt, and S. J. Lee, Economics of hematopoietic cell transplantation, Blood, vol.120, pp.1545-51, 2012.

A. Gratwohl, M. C. Pasquini, M. Aljurf, Y. Atsuta, H. Baldomero et al., One million haemopoietic stem-cell transplants: a retrospective observational study, Lancet Haematol, vol.2, pp.91-100, 2015.

J. R. Passweg, H. Baldomero, P. Bader, C. Bonini, S. Cesaro et al., Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants, Bone Marrow Transplant, vol.50, pp.476-82, 2015.

D. Blaise, R. Devillier, A. Lecoroller-sorriano, J. Boher, A. Boyer-chammard et al., Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic stem cell transplantation: a prospective multicenter phase II trial, Haematologica, vol.100, pp.269-74, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02167058

L. Gragert, M. Eapen, E. Williams, J. Freeman, S. Spellman et al., HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry, N Engl J Med, vol.371, pp.339-387, 2014.

W. Saber, S. Opie, J. D. Rizzo, M. Zhang, M. M. Horowitz et al., Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia, Blood, vol.119, pp.3908-3924, 2012.

F. R. Appelbaum, Allogeneic hematopoietic cell transplantation for acute myeloid leukemia when a matched related donor is not available, Hematology, pp.412-419, 2008.

T. V. Joshua, J. D. Rizzo, M. Zhang, P. N. Hari, S. Kurian et al., Access to hematopoietic stem cell transplantation: effect of race and sex, Cancer, vol.116, pp.3469-76, 2010.

E. W. Petersdorf, Limits of HLA mismatching in unrelated hematopoietic cell transplantation, Blood, vol.104, pp.2976-80, 2004.

N. Kekre and J. H. Antin, Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist, Blood, vol.124, pp.334-377, 2014.

F. R. Appelbaum, Alternative donor transplantation for adults with acute leukemia, Best Pract Res Clin Haematol, vol.27, pp.272-279, 2014.

A. M. Raiola, A. Dominietto, C. Di-grazia, T. Lamparelli, F. Gualandi et al., Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, vol.20, pp.1573-1582, 2014.

D. Stasi, A. Milton, D. R. Poon, L. M. Hamdi, A. Rondon et al., Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, vol.20, pp.1975-81, 2014.

S. O. Ciurea, M. Zhang, A. A. Bacigalupo, A. Bashey, F. R. Appelbaum et al., Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia, Blood, vol.126, pp.1033-1073, 2015.

M. Shabbir-moosajee, L. Lombardi, and S. O. Ciurea, An overview of conditioning regimens for haploidentical stem cell transplantation with post-transplantation cyclophosphamide, Am J Hematol, vol.90, pp.541-549, 2015.

J. M. Goldman, R. Szydlo, M. M. Horowitz, R. P. Gale, R. C. Ash et al., Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase, Blood, vol.82, pp.2235-2243, 1993.

J. E. Maraninchi, D. Reiffers, J. Archimbaud, E. Michallet, M. Harousseau et al., Allogeneic bone marrow transplantation remains an efficient consolidation for adults with acute myeloid leukemia even when performed very soon after diagnosis (<100 days). The SFGM (Société Française de Greffe de Moelle, Leukemia, vol.9, pp.1068-71, 1995.

A. Gratwohl, The EBMT risk score, Bone Marrow Transplant, vol.47, pp.749-56, 2012.

D. Blaise, S. Fürst, R. Crocchiolo, J. El-cheikh, A. Granata et al., Haploidentical T cell-replete transplantation with posttransplantation cyclophosphamide for patients in or above the sixth decade of age compared with allogeneic hematopoietic stem cell transplantation from an human leukocyte antigen-matched related or unrelated donor, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, vol.22, pp.119-143, 2015.

R. Burns, J. Leal, R. Sullivan, and R. Luengo-fernandez, Economic burden of malignant blood disorders across Europe: a populationbased cost analysis, Lancet Haematol, vol.3, pp.362-70, 2016.
DOI : 10.1016/s2352-3026(16)30062-x

A. M. Saito, C. Cutler, D. Zahrieh, R. J. Soiffer, V. T. Ho et al., Costs of allogeneic hematopoietic cell transplantation with high-dose regimens, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, vol.14, pp.197-207, 2008.

N. Khera, A. Emmert, B. E. Storer, B. M. Sandmaier, E. P. Alyea et al., Costs of allogeneic hematopoietic cell transplantation using reduced intensity conditioning regimens, Oncologist, vol.19, pp.639-683, 2014.
DOI : 10.1634/theoncologist.2013-0406
URL : http://theoncologist.alphamedpress.org/content/19/6/639.full.pdf

B. Svahn, M. Remberger, A. O. Karlsson, H. Ringdén, and O. Debals-gonthier, Increased costs after allogeneic haematopoietic SCT are M
DOI : 10.1016/j.bbmt.2011.12.354
URL : https://doi.org/10.1016/j.bbmt.2011.12.354

, associated with major complications and re-transplantation, Bone Marrow Transplant, vol.47, pp.706-721, 2012.

K. J. Suh, I. Kim, J. Lim, H. Ha, S. Park et al., Total costs and clinical outcome of hematopoietic stem cell transplantation in adults with leukemia: comparison between reduced-intensity and myeloablative conditioning, Clin Transplant, vol.29, pp.124-157, 2015.

S. Matthes-martin, U. Pötschger, R. Barr, M. Martin, H. Boztug et al., Costs and cost-effectiveness of allogeneic stem cell transplantation in children are predictable, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, vol.18, pp.1533-1542, 2012.

E. J. Fuchs, Related haploidentical donors are a better choice than matched unrelated donors: point, Blood Adv, vol.1, pp.397-400, 2017.

B. E. Shawn, Related haploidentical donors are a better choice than matched unrelated donors: counterpoint, Blood Adv, vol.1, pp.401-407, 2017.

, Agence Technique de l'Information sur l'Hospitalisation. Référentiel de couts MCO, 2014.

, Agence Technique de l'Information sur l'Hospitalisation, 2016.

, Agence Technique de l'Information sur l'Hospitalisation. Référentiel de couts SSR, 2014.

, Agence Technique de l'Information sur l'Hospitalisation, 2016.

, Caisse Nationale de l'Assurance Maladie des Travailleurs Salariés. Nomenclature des Actes de Biologie Médicale v 42. Caisse Nationale de l'Assurance Maladie des Travailleurs Salariés, 2014.

, Caisse Nationale de l'Assurance Maladie des Travailleurs Salariés. Classification Commune des Actes Médicaux v 37. Caisse Nationale de l'Assurance Maladie des Travailleurs Salariés, 2014.

M. Santé, Arrêté du 7 avril 2014 modifiant l'arrêté du 9 mars 2010 modifié relatif au tarif de cession des produits sanguins labiles

H. Autorité-de-santé, Choix méthodologiques pour l'évaluation économique à la HAS, 2011.

M. F. Drummond, M. J. Sculpher, K. Claxton, G. L. Stoddart, and G. W. Torrance, Methods for the economic evaluation of health care programmes, p.445, 2015.

C. De-peretti and C. Siani, Decision-making with the incremental costeffectiveness ratio under uncertainty, Health Syst Sci, vol.9, pp.111-156, 2006.
URL : https://hal.archives-ouvertes.fr/hal-01510981

E. C. Fieller, Some problems in interval estimation, J R Stat Soc Ser B Methodol, vol.16, pp.175-85, 1954.

C. Siani, D. Peretti, and C. , The performance of Fieller's method in problematic cases often occuring in practice, Health Syst Sci, vol.9, pp.205-231, 2006.

K. Claxton, M. Sculpher, C. Mccabe, A. Briggs, R. Akehurst et al., Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra, Health Econ, vol.14, pp.339-386, 2005.
DOI : 10.1002/hec.985
URL : http://download.clib.psu.ac.th/datawebclib/e_resource/trial_database/WileyInterScienceCD/pdf/HEC/HEC_4.pdf

N. S. Majhail, J. M. Mothukuri, M. L. Macmillan, M. R. Verneris, P. J. Orchard et al., Costs of pediatric allogeneic hematopoietic-cell transplantation, Pediatr Blood Cancer, vol.54, pp.138-181, 2010.
DOI : 10.1002/pbc.22250
URL : http://europepmc.org/articles/pmc4111794?pdf=render

J. M. Preussler, E. M. Denzen, and N. S. Majhail, Costs and costeffectiveness of hematopoietic cell transplantation, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, vol.18, pp.1620-1628, 2012.

R. Busse, J. Schreyögg, and P. C. Smith, Variability in healthcare treatment costs amongst nine EU countries-results from the HealthBASKET project, Health Econ, vol.17, issue.1, pp.1-8, 2008.

N. S. Majhail, L. W. Mau, E. M. Denzen, and T. J. Arneson, Costs of autologous and allogeneic hematopoietic cell transplantation in the United States: a study using a large national private claims database, Bone Marrow Transplant, vol.48, pp.294-300, 2013.

M. Van-agthoven, M. T. Groot, L. F. Verdonck, B. Löwenberg, A. Schattenberg et al., Cost analysis of HLAidentical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia, Bone Marrow Transplant, vol.30, pp.243-51, 2002.

, European Central Bank. Inflation dashboard

, European Central Bank, p.13, 2016.

J. R. Passweg, H. Baldomero, M. Bregni, S. Cesaro, P. Dreger et al., Hematopoietic SCT in Europe: data and trends in 2011, Bone Marrow Transplant, vol.48, pp.1161-1168, 2013.

M. L. Sorror, Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT, Blood, vol.106, pp.2912-2921, 2005.

P. Armand, C. J. Gibson, C. Cutler, V. T. Ho, J. Koreth et al., A disease risk index for patients undergoing allogeneic stem cell transplantation, Blood, vol.120, pp.905-918, 2012.

D. Blaise, R. Tabrizi, J. Boher, L. Corroller-soriano, A. Bay et al., Randomized study of 2 reduced-intensity conditioning strategies for human leukocyte antigen-matched, related allogeneic peripheral blood stem cell transplantation: prospective clinical and socioeconomic evaluation, Cancer, vol.119, pp.602-613, 2013.